Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Bill Gates: Alzheimer's Cure Targeted With $100 Million in Donations

Newsmax Monday, 13 November 2017 ()
Bill Gates: Alzheimer's Cure Targeted With $100 Million in DonationsBill Gates is targeting an Alzheimer's cure by donating $50 million to the Dementia Discovery Fund and another $50 million for startup ventures.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Wochit News - < > Embed
News video: Bill Gates Donating $100 Million to Help Battle Alzheimer's

Bill Gates Donating $100 Million to Help Battle Alzheimer's 00:42

On Monday, Microsoft founder Bill Gates said he is donating $100 million to fight Alzheimer’s disease. Gates, who said he has a family history of Alzheimer’s, the most common form of dementia, added, "This is something I know a lot about, because men in my family have suffered from...

You Might Like


Recent related news

Bill Gates Gives $50 Million To Find Cure For Alzheimer’s

Bill Gates says he's giving $50 million to help fight Alzheimer's disease.
cbs4.com - USAlso reported by •MashableWorldNewsSeattlePI.comUSATODAY.comFuturismSydney Morning HeraldRTTNewsNewsmaxReuters IndiaMyjoyonlineSeattle Times

Other recent news in US

Cult leader and murderer Charles MANSON dies at 83CHARLES MANSON, Keystone XL, N.F.L.: Your Monday Briefing
MANSON DIES At 83. Lead Cult Members Who Committed 1969 MurdersSee a full list of THANKSGIVING and Black Friday hours for New Orleans retailers
Nebraska regulators approve KEYSTONE XL pipeline route: panel voteGEORGIA DOME stadium crumbles in controlled demolition
Senator AL FRANKEN accused of misconduct by second womanDella Reese, Of CBS’ ‘TOUCHED BY AN ANGEL,’ Has Died At 86
Trump Designates NORTH KOREA as a State Sponsor of TerrorismSenate candidate ROY MOORE's accuser: I was a 14-year-old child

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+